1.
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
by Zhang, W
Annals of the rheumatic diseases, 2008, Vol.67 (12), p.1716-1723
2.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
by le Roux, Carel W, Prof
The Lancet (British edition), 2017, Vol.389 (10077), p.1399-1409
3.
Adalimumab for the treatment of fistulas in patients with Crohn’s disease
by Colombel, J-F
Gut, 2009, Vol.58 (7), p.940-948
4.
Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial
by Schaefer, Michael
Psychotherapy and psychosomatics, 2016, Vol.85 (6), p.373-374
5.
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double...
by Lee, Nancy Y
The lancet oncology, 2021, Vol.22 (4), p.450-462
6.
Age and Sex as Moderators of the Placebo Response - An Evaluation of Systematic Reviews and Meta-Analyses across Medicine
by Weimer, Katja
Gerontology (Basel), 2015, Vol.61 (2), p.97-108
7.
Placebo Analgesia: A Predictive Coding Perspective
by Büchel, Christian
Neuron (Cambridge, Mass.), 2014, Vol.81 (6), p.1223-1239
8.
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
by Nassif, Michael E
Nature medicine, 2021, Vol.27 (11), p.1954-1960
9.
Biological, clinical, and ethical advances of placebo effects
by Finniss, Damien G, Dr
The Lancet (British edition), 2010, Vol.375 (9715), p.686-695
10.
The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes
by Chavarria, Victor, MD
Clinical therapeutics, 2017, Vol.39 (3), p.477-486
11.
Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
by Tracey, Irene
Nature medicine, 2010, Vol.16 (11), p.1277-1283
12.
Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers
by Schmid, Julia
Gut, 2015, Vol.64 (3), p.418-427
13.
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and Clinical Immunology PRACTALL c...
by Sampson, Hugh A., MD
Journal of allergy and clinical immunology, 2012, Vol.130 (6), p.1260-1274
14.
Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut
by Santos, Alexandra F., MD, MSc
Journal of allergy and clinical immunology, 2014, Vol.135 (1), p.179-186
15.
New Insights into the Placebo and Nocebo Responses
by Enck, Paul
Neuron (Cambridge, Mass.), 2008, Vol.59 (2), p.195-206
16.
“Managing” the Placebo Effect: The Single-Blind Placebo Lead-in Response in Two Pain Models
by Harden, R. Norman
Pain medicine (Malden, Mass.), 2016, Vol.17 (12), p.2305-2310
17.
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy
by Shang, Aijing
The Lancet (British edition), 2005, Vol.366 (9487), p.726-732
18.
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
by Mega, JL, MD
The Lancet (British edition), 2009, Vol.374 (9683), p.29-38
19.
Sham surgical procedures for pain intervention result in significant improvements in pain: Systematic-review and meta-analysis
by Gu, Alice P., M.P.H
Journal of clinical epidemiology, 2017, Vol.83, p.18-23
20.
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
by Kyriazopoulou, E
Nature medicine, 2021, Vol.27 (10), p.1752-1760
